Black Diamond Therapeutics, Inc.
BDTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36 | $56 | $34 | $66 |
| Short-Term Investments | $62 | $75 | $88 | $144 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $3 | $5 | $0 |
| Total Curr. Assets | $101 | $134 | $128 | $216 |
| Property Plant & Equip (Net) | $20 | $24 | $27 | $31 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $21 | $25 | $29 | $32 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $123 | $159 | $156 | $248 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $2 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $21 | $20 | $15 | $24 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $19 | $22 | $25 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $22 | $25 | $28 | $28 |
| Total Liabilities | $39 | $42 | $41 | $52 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$487 | -$417 | -$335 | -$244 |
| AOCI | $0 | -$0 | -$2 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $83 | $117 | $116 | $196 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $123 | $159 | $156 | $248 |
| Net Debt | -$36 | -$56 | -$34 | -$66 |